Conference

10th Annual Clinical Trial Supply Chain Korea 2025

Dec 02, 2025 - Dec 03, 2025

Seoul, South Korea

Join us at the Clinical Trials Supply Korea 2025, the premier event for professionals in the clinical trials industry! This is your exclusive opportunity to connect with industry leaders, gain insights into the latest trends, and explore innovative solutions that are shaping the future of clinical trials supply. Held in the vibrant city of Seoul, this event promises to deliver unparalleled networking opportunities, thought-provoking discussions, and actionable strategies to enhance your supply chain operations. Whether you're looking to optimize your logistics, ensure regulatory compliance, or discover cutting-edge technologies, CTS Korea 2025 is the place to be. Don't miss out on the chance to collaborate with peers, learn from experts, and drive your business forward in this dynamic field. Secure your spot today and be part of the conversation that will define the future of clinical trials supply in Korea and beyond. Visit our event page for more details and registration: https://www.arena-international.com/event/ctskorea/. Get ready to elevate your professional journey and make a lasting impact in the industry!

About the Organiser

Arena International

Day and Timing

Tuesday, Dec 2 - 3

Location

Seoul, South Korea

Entry Fees

Paid

Frequency

Annual

Event Type

Conference

Duration

2 Days

Website

arena-international.com

Day and Timing

Tuesday, Dec 2 - 3

Location

Seoul, South Korea

Entry Fees

Paid

Frequency

Annual

Event Type

Conference

Duration

2 Days

Website

arena-international.com

About the Organiser

Arena International

Ad
Advertisement

More Events

Conference

Biologics X 3DCC 2026

Jan 22, 2026 - Jan 23, 2026

Goa, India

Conference

Drug Safety Symposium 2026

Jan 21, 2026 - Jan 22, 2026

Dubai, UAE

Conference

Pittcon 2026 Conference + Expo

Mar 07, 2026 - Mar 11, 2026

Texas, USA

View All

News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news